Healthcare AI Acquisition Corp. Unit
HAIAU
HAIAU was delisted on the 6th of December, 2024.
9 hedge funds and large institutions have $5.19M invested in Healthcare AI Acquisition Corp. Unit in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 5 closing their positions.
31% less funds holding
Funds holding: 13 → 9 (-4)
74% less capital invested
Capital invested by funds: $20M → $5.19M (-$14.8M)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Calamos Advisors
Naperville,
Illinois
|
-$10.1M |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
-$4.57M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$564K |
| 4 |
AR
Advisory Research
Chicago,
Illinois
|
-$278K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$82.1K |
HAIAU Hedge Fund Activity: Q4 2022 in Review
9 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Healthcare AI Acquisition Corp. Unit (HAIAU) for Q4 2022, worth a combined $5.19M — down 74% from $20M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of HAIAU and 1 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 0 added.
The largest seller was Calamos Advisors, exiting entirely with an estimated $10.1M sold.
- 9 institutional investors held Healthcare AI Acquisition Corp. Unit (HAIAU) as of Q4 2022, down from 13 in Q3 2022.
- Funds reported $5.19M of Healthcare AI Acquisition Corp. Unit stock for Q4 2022, down 74% quarter-over-quarter.
- 1 fund opened new Healthcare AI Acquisition Corp. Unit positions in Q4 2022 and 5 closed out, a net change of -4 holders.
- The largest Healthcare AI Acquisition Corp. Unit seller in Q4 2022 was Calamos Advisors, an estimated $10.1M sold.
Based on aggregated 13F filings for Q4 2022.